Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREPARE feasibility randomized trial of tirzepatide-based preconception weight management in women with obesity and infertility
2026-526869-19-00Phase 4Authorised
- Sponsor
- University College Dublin
- Start
- Oct 2026
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tirzepatide in obesity and female infertility (2 arms), sponsored by University College Dublin. Primary endpoints: Recruitment rate, Retention rate and 3 more. Planned start Oct 2026; status: authorised.
02
Drugs
03
Conditions
obesityfemale infertility
Beyond the preview
Go deeper on 2026-526869-19-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2026-526869-19-00.